Food and Drug Administration (FDA) Funding This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R24)
Funding Opportunity RFA-HL-17-030 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications, from investigators with active R24 research project awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of the project's approved scope or r...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 28, 2017 Category: Research Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R01)
Funding Opportunity RFA-HL-17-029 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications, from investigators with active R01 research project awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of the project's approved scope or r...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 28, 2017 Category: Research Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM2)
Funding Opportunity RFA-HL-17-031 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications from investigators with active UM2 Program Project or Center with Complex Structure Cooperative Agreement awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget peri...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 28, 2017 Category: Research Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P50)
Funding Opportunity RFA-HL-17-032 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications from investigators with active P50 specialized center awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of the project's approved scope or ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 28, 2017 Category: Research Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM1)
Funding Opportunity RFA-HL-17-026 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite invites revision applications, from investigators with active UM1 research project awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of the project's approved sc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 28, 2017 Category: Research Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P41)
Funding Opportunity RFA-HL-17-033 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications from investigators with active P41 research project awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of the project's approved scope or re...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 28, 2017 Category: Research Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U54)
Funding Opportunity RFA-HL-17-025 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications from investigators with active U54 research project awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of the project's approved scope or re...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 28, 2017 Category: Research Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U24)
Funding Opportunity RFA-HL-17-028 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications, from investigators with active U24 research project awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of the project's approved scope or r...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 28, 2017 Category: Research Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UC4)
Funding Opportunity RFA-HL-17-027 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications, from investigators with active UC4 research project awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of the project's approved scope or r...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 28, 2017 Category: Research Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R41/R42)
Funding Opportunity RFA-HL-17-024 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications from investigators with active R41/R42 Small Business Technology Transfer (STTR) Grant awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 28, 2017 Category: Research Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R43/R44)
Funding Opportunity RFA-HL-17-023 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications from investigators with active R43/R44 Small Business Innovation Research Grants (SBIR) awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion o...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 28, 2017 Category: Research Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P41)
The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications from investigators with active P41 research project awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of the project's approved scope or research protocol. These revision applications are expected to focus on innovative p...
Source: NIDDK Funding Opportunities - April 28, 2017 Category: Endocrinology Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U01)
The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications, from investigators with active U01 research project awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of the project's approved scope or research protocol. These revision applications are expected to focus on innovative ...
Source: NIDDK Funding Opportunities - April 28, 2017 Category: Endocrinology Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U24)
The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications, from investigators with active U24 research project awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of the project's approved scope or research protocol. These revision applications are expected to focus on innovative ...
Source: NIDDK Funding Opportunities - April 28, 2017 Category: Endocrinology Source Type: funding

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UC4)
The National Institutes of Health (NIH) and participating NIH Institutes and Centers (ICs) and the U.S. Food and Drug Administration (FDA), through this Funding Opportunity Announcement (FOA), invite revision applications, from investigators with active UC4 research project awards that will support clinical research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. A competing revision is a request for an increase in support in a current budget period for expansion of the project's approved scope or research protocol. These revision applications are expected to focus on innovative ...
Source: NIDDK Funding Opportunities - April 28, 2017 Category: Endocrinology Source Type: funding